Market research
VPT.V VentriPoint Diagnostics Ltd
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.04
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA92281P2008
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.04
About
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the VPT.V discussion.
5 years, 5 months ago
VentriPoint Diagnostics Ltd is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.
From a valuation standpoint, the stock is 12.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 888.9.
VentriPoint Diagnostics Ltd's total revenue rose by inf% to $6K since the same quarter in the previous year.
Its net income has dropped by 12.0% to $-608K since the same quarter in the previous year.
Finally, its free cash flow fell by 54.3% to $-197K since the same quarter in the previous year.
Based on the above factors, VentriPoint Diagnostics Ltd gets an overall score of 3/5.